Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy
Wienke, Judith; Visser, Lindy L; Kholosy, Waleed M; Keller, Kaylee M; Barisa, Marta; Poon, Evon; Munnings-Tomes, Sophie; Himsworth, Courtney; Calton, Elizabeth; Rodriguez, Ana; Bernardi, Ronald; van den Ham, Femke; van Hooff, Sander R; Matser, Yvette A H; Tas, Michelle L; Langenberg, Karin P S; Lijnzaad, Philip; Borst, Anne L; Zappa, Elisa; Bergsma, Francisca J; Strijker, Josephine G M; Verhoeven, Bronte M; Mei, Shenglin; Kramdi, Amira; Restuadi, Restuadi; Sanchez-Bernabeu, Alvaro; Cornel, Annelisa M; Holstege, Frank C P; Gray, Juliet C; Tytgat, Godelieve A M; Scheijde-Vermeulen, Marijn A; Wijnen, Marc H W A; Dierselhuis, Miranda P; Straathof, Karin; Behjati, Sam; Wu, Wei; Heck, Albert J R; Koster, Jan; Nierkens, Stefan; Janoueix-Lerosey, Isabelle; de Krijger, Ronald R; Baryawno, Ninib; Chesler, Louis; Anderson, John; Caron, Hubert N; Margaritis, Thanasis; van Noesel, Max M; Molenaar, Jan J
(2024) Cancer Cell, volume 42, issue 2, pp. 283 - 300.e8
(Article)
Abstract
Pediatric patients with high-risk neuroblastoma have poor survival rates and urgently need more effective treatment options with less side effects. Since novel and improved immunotherapies may fill this need, we dissect the immunoregulatory interactions in neuroblastoma by single-cell RNA-sequencing of 24 tumors (10 pre- and 14 post-chemotherapy, including 5 pairs)
... read more
to identify strategies for optimizing immunotherapy efficacy. Neuroblastomas are infiltrated by natural killer (NK), T and B cells, and immunosuppressive myeloid populations. NK cells show reduced cytotoxicity and T cells have a dysfunctional profile. Interaction analysis reveals a vast immunoregulatory network and identifies NECTIN2-TIGIT as a crucial immune checkpoint. Combined blockade of TIGIT and PD-L1 significantly reduces neuroblastoma growth, with complete responses (CR) in vivo. Moreover, addition of TIGIT+PD-L1 blockade to standard relapse treatment in a chemotherapy-resistant Th-ALK F1174L/MYCN 129/SvJ syngeneic model induces CR. In conclusion, our integrative analysis provides promising targets and a rationale for immunotherapeutic combination strategies.
show less
Download/Full Text
Keywords: Immune checkpoint inhibition, NECTIN2, Neuroblastoma, PD-1, PD-L1, Pediatric oncology, TIGIT, immune evasion, immunotherapy, tumor microenvironment, Oncology, Cancer Research
ISSN: 1535-6108
Publisher: Cell Press
Note: Publisher Copyright: © 2023 The Authors
(Peer reviewed)
